TerminatedPhase 2NCT00638820

Reduced Intensity AlloTransplant For Osteopetrosis

Studying Albers-Schönberg osteopetrosis

Last synced from ClinicalTrials.gov May 4, 2026

ℹ

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.

Report missing data

Key facts

Sponsor: Masonic Cancer Center, University of Minnesota
Principal Investigator: Paul Orchard, MD, D.D.S
Masonic Cancer Center, University of Minnesota
Intervention: Stem Cell or Umbilical Cord Blood Transplantation(procedure)
Enrollment: 3 enrolled
Eligibility: 45 years · All sexes
Timeline: 2007 – 2008

Study locations (1)

University of MInnesota, Fairview, Minneapolis, Minnesota, United States

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT00638820 on ClinicalTrials.gov

← Back to all trials